Penumbra Inc (NYSE:PEN) EVP Lynn Rothman sold 6,000 shares of the stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $125.02, for a total transaction of $750,120.00. Following the completion of the sale, the executive vice president now owns 144,319 shares of the company’s stock, valued at approximately $18,042,761.38. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Lynn Rothman also recently made the following trade(s):
- On Tuesday, March 6th, Lynn Rothman sold 3,727 shares of Penumbra stock. The stock was sold at an average price of $115.01, for a total transaction of $428,642.27.
- On Wednesday, February 28th, Lynn Rothman sold 2,273 shares of Penumbra stock. The stock was sold at an average price of $115.00, for a total transaction of $261,395.00.
- On Tuesday, January 16th, Lynn Rothman sold 6,000 shares of Penumbra stock. The stock was sold at an average price of $90.99, for a total transaction of $545,940.00.
NYSE:PEN traded up $1.90 during midday trading on Thursday, reaching $124.15. The stock had a trading volume of 332,345 shares, compared to its average volume of 294,512. Penumbra Inc has a 1-year low of $77.75 and a 1-year high of $127.40. The firm has a market capitalization of $4,175.93, a PE ratio of -12,205.00, a PEG ratio of 44.49 and a beta of 0.01.
Penumbra (NYSE:PEN) last posted its earnings results on Tuesday, February 27th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. Penumbra had a net margin of 1.40% and a negative return on equity of 0.23%. The business had revenue of $96.05 million for the quarter, compared to analyst estimates of $87.69 million. equities analysts anticipate that Penumbra Inc will post 0.14 EPS for the current fiscal year.
A number of large investors have recently bought and sold shares of PEN. BlackRock Inc. boosted its holdings in Penumbra by 1.4% in the 4th quarter. BlackRock Inc. now owns 1,939,033 shares of the company’s stock valued at $182,462,000 after purchasing an additional 26,949 shares during the period. Redmile Group LLC boosted its holdings in Penumbra by 9.2% in the 4th quarter. Redmile Group LLC now owns 617,279 shares of the company’s stock valued at $58,086,000 after purchasing an additional 51,768 shares during the period. Eagle Asset Management Inc. boosted its holdings in Penumbra by 10.3% in the 3rd quarter. Eagle Asset Management Inc. now owns 563,290 shares of the company’s stock valued at $51,991,000 after purchasing an additional 52,372 shares during the period. Carillon Tower Advisers Inc. bought a new stake in Penumbra in the 4th quarter valued at $33,998,000. Finally, Clearbridge Investments LLC boosted its holdings in Penumbra by 0.3% in the 4th quarter. Clearbridge Investments LLC now owns 318,089 shares of the company’s stock valued at $29,932,000 after purchasing an additional 1,037 shares during the period. Institutional investors and hedge funds own 73.41% of the company’s stock.
Several research analysts have recently commented on PEN shares. Canaccord Genuity restated a “buy” rating and set a $125.00 price target on shares of Penumbra in a research note on Thursday, April 5th. Goldman Sachs started coverage on shares of Penumbra in a research note on Wednesday, April 4th. They set a “buy” rating and a $145.00 price target on the stock. Zacks Investment Research upgraded shares of Penumbra from a “sell” rating to a “hold” rating in a research note on Wednesday, January 17th. BMO Capital Markets increased their price target on shares of Penumbra from $110.00 to $115.00 and gave the stock a “market perform” rating in a research note on Wednesday, February 28th. Finally, JPMorgan Chase lowered shares of Penumbra from an “overweight” rating to a “neutral” rating in a research note on Tuesday, January 2nd. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $130.75.
ILLEGAL ACTIVITY NOTICE: “Penumbra Inc (PEN) EVP Sells $750,120.00 in Stock” was published by Macon Daily and is the property of of Macon Daily. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://macondaily.com/2018/04/12/lynn-rothman-sells-6000-shares-of-penumbra-inc-pen-stock-updated-updated-updated.html.
Penumbra Company Profile
Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.
Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.